microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6.
暂无分享,去创建一个
Tianyu Li | T. Kuang | Yue Fan | Chen-Ye Shi
[1] R. Moffitt,et al. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer , 2016, Oncotarget.
[2] G. Tsongalis,et al. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia. , 2016, Clinical biochemistry.
[3] Y. Shang,et al. DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1 , 2016, Oncotarget.
[4] Xiangnan Li,et al. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Yonghui Wang,et al. Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway , 2016, Oncotarget.
[6] D. Tuveson,et al. Title : Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis , 2016 .
[7] I. Herr,et al. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. , 2016, Cancer letters.
[8] Wei Wei,et al. MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma , 2016, Scientific Reports.
[9] Yao Liu,et al. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3 , 2016, Oncotarget.
[10] Ș. Purcaru,et al. New perspectives in glioblastoma antiangiogenic therapy , 2015, Contemporary oncology.
[11] Shan Wang,et al. Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p. , 2015, Cancer letters.
[12] Jie Zhao,et al. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6. , 2015, Oncology reports.
[13] Lei Sun,et al. MicroRNA‐454 functions as an oncogene by regulating PTEN in uveal melanoma , 2015, FEBS letters.
[14] R. Evans,et al. Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer , 2015, Molecular Cancer Research.
[15] Guangfeng Niu,et al. miR‐454 is down‐regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c‐Met , 2015, Cell proliferation.
[16] Shangfeng Liu,et al. LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis , 2015, Nature Communications.
[17] G. Davidson,et al. CD44 functions in Wnt signaling by regulating LRP6 localization and activation , 2014, Cell Death and Differentiation.
[18] T. Psaltopoulou,et al. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[19] Michael Simons,et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. , 2014, Cancer cell.
[20] T. Gress,et al. Current concepts and novel targets in advanced pancreatic cancer , 2012, Gut.
[21] Xin Zhou,et al. Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1α protein accumulation and vascular endothelial growth factor expression in human breast cancer cells , 2009, Acta Pharmacologica Sinica.
[22] M. Korc,et al. Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines , 2004, Clinical Cancer Research.
[23] L. Ellis,et al. Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases. , 2001, Cancer biotherapy & radiopharmaceuticals.